In addition to rumors of Dendreon (DNDN +5%) looking to sell itself, the stock also appears to be reacting to Provenge's recent inclusion on the European Medicines Agencies XEVMPD, a medicinal products dictionary that outlines a drug's basic product details. Submission of product data to the XEVMPD is now mandatory for all drugs registered in the European Union.
Are you Bullish or Bearish on ?
Sentiment on ()
Thanks for sharing your thoughts.